Murae Organisor
Key Fundamentals
MicrocapPharmaceuticalsHealthcarePrice-based figures · TTM
- ROCE
- 4.20%
- Debt to Equity
- 1.02
- EPS (TTM)
- ₹0.20
- Book Value
- ₹1.02
- Market Cap
- —
- P/E (TTM)
- —
- P/B
- —
- ROE
- 5.69%
- Dividend Yield
- 0.00%
- EBITDA
- —
- 52W High
- —
- 52W Low
- —
Key Insights
Strengths
3- Stock is trading at 0.19 times its book value
- Company has delivered good profit growth of 32.8% CAGR over last 5 years
- Debtor days have improved from 517 to 108 days.
Weaknesses
4- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 5.10% over last 3 years.
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.9.00 Cr.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 12 | 5 | 2 |
| Oscillators | Neutral | 2 | 5 | 2 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |
Oscillators
Neutral
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 37.77
- Neutral
- MACD (12,26,9)
- −0.01
- Bearish
- SMA (50)
- 0.22
- Bearish
- SMA (200)
- 0.44
- Bearish
As of , the latest day with price data, so these readings are not current.
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2025; 1Y: fiscal year to Mar 2025 against Mar 2024.
Revenue
| 10Y | +57.68% |
|---|---|
| 5Y | +73.11% |
| 3Y | +244.02% |
| 1Y | Tiny base |
Net profit
| 10Y | Zero base |
|---|---|
| 5Y | +31.95% |
| 3Y | +58.74% |
| 1Y | Zero base |
Operating cash flow
| 10Y | Outflow widened by ₹321 Cr |
|---|---|
| 5Y | Outflow widened by ₹320 Cr |
| 3Y | Turned negative |
| 1Y | Outflow widened by ₹307 Cr |
Operating margin· change in pp
| 10Y | +1.17 pp |
|---|---|
| 5Y | −0.65 pp |
| 3Y | +20.22 pp |
| 1Y | +1.17 pp |
Trailing twelve months: The latest quarterly results are more than a year old.
Revenue by year
| Mar 2016 | ₹19.00 Cr |
|---|---|
| Mar 2017 | ₹23.00 Cr |
| Mar 2018 | ₹35.00 Cr |
| Mar 2019 | ₹51.00 Cr |
| Mar 2020 | ₹55.00 Cr |
| Mar 2021 | ₹41.00 Cr |
| Mar 2022 | ₹21.00 Cr |
| Mar 2023 | ₹14.00 Cr |
| Mar 2024 | ₹3.00 Cr |
| Mar 2025 | ₹855 Cr |
Net profit by year
| Mar 2016 | ₹0.00 Cr |
|---|---|
| Mar 2017 | ₹0.00 Cr |
| Mar 2018 | ₹1.00 Cr |
| Mar 2019 | ₹2.00 Cr |
| Mar 2020 | ₹2.00 Cr |
| Mar 2021 | ₹0.00 Cr |
| Mar 2022 | ₹2.00 Cr |
| Mar 2023 | ₹2.00 Cr |
| Mar 2024 | ₹0.00 Cr |
| Mar 2025 | ₹8.00 Cr |
Quarterly Results
₹ CrResults for the period ended Sep 2025 were due by 14 Nov 2025 and are not in this table yet.
| Particulars | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4.28 | 7.11 | 1.17 | 1.53 | 1.71 | 0.43 | 0.4 | 0.86 | 0.23 | 58.01 | 281 | 516 | 3.99 |
| Expenses | 4.76 | 7.05 | 1.04 | 0.32 | 2.37 | 1.38 | 0.34 | −0.44 | 0.47 | 56.88 | 276 | 512 | 3.05 |
| Operating Profit | −0.48 | 0.06 | 0.13 | 1.21 | −0.66 | −0.95 | 0.06 | 1.3 | −0.24 | 1.13 | 5.26 | 3.89 | 0.94 |
| OPM % | −11.21% | 0.84% | 11.11% | 79.08% | −38.6% | −220.93% | 15% | 151.16% | −104.35% | 1.95% | 1.87% | 0.75% | 23.56% |
| Other Income | 0.87 | 0 | 1.4 | 0 | 0.66 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 |
| Interest | 0 | 0 | 0.14 | 0.15 | 0.26 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 0.37 | 0.04 | 1.36 | 1.03 | −0.28 | −0.98 | 0.04 | 1.3 | −0.24 | 1.13 | 5.26 | 3.89 | 9.94 |
| Tax % | 0% | 0% | 0% | 74.76% | 0% | −11.22% | 0% | 10% | 0% | 19.47% | 23.76% | 26.74% | 25.15% |
| Net Profit | 0.36 | 0.04 | 1.37 | 0.26 | −0.28 | −0.87 | 0.04 | 1.17 | −0.24 | 0.9 | 4.01 | 2.85 | 7.44 |
| EPS (₹) | 0 | 0 | 0.02 | 0 | 0 | −0.01 | 0 | 0.02 | 0 | 0 | 0.02 | 0.01 | 0.04 |
Profit & Loss
₹ Cr| Particulars | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 9 | 19 | 23 | 35 | 51 | 55 | 41 | 21 | 14 | 3 | 855 | 859 |
| Expenses | 0 | 9 | 18 | 23 | 34 | 47 | 54 | 49 | 25 | 13 | 4 | 845 | 847 |
| Operating Profit | 0 | 0 | 1 | 0 | 2 | 3 | 1 | −8 | −4 | 1 | 0 | 10 | 11 |
| OPM % | — | 2.4% | 2.8% | 1.8% | 4.4% | 7% | 2.2% | −19% | −21% | 7% | −15% | 1.2% | 1.3% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 9 | 8 | 2 | 1 | 0 | 9 |
| Interest | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 0 | 3 | 3 | 0 | 10 | 20 |
| Tax % | — | 31% | 44% | 33% | 27% | 27% | 26% | 25% | 28% | 29% | 29% | 25% | — |
| Net Profit | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 0 | 2 | 2 | 0 | 8 | 15 |
| EPS (₹) | — | — | 0 | 0.01 | 0.02 | 0.03 | 0.02 | 0 | 0.02 | 0.02 | 0 | 0.04 | 0.07 |
| Div. Payout % | — | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 0.11 | 0.11 | 0.31 | 0.31 | 6 | 6 | 12 | 12 | 49 | 186 |
| Reserves | 0 | 1 | 1 | 1 | 5 | 6 | 8 | 8 | 4 | 6 | 6 | 23 |
| Borrowings | 0 | 1 | 2 | 2 | 7 | 10 | 9 | 11 | 9 | 9 | 0 | 213 |
| Other Liabilities | 0 | 3 | 6 | 7 | 7 | 8 | 12 | 2 | 3 | 1 | 64 | 231 |
| Total Liabilities | 0 | 5 | 9 | 11 | 20 | 23 | 36 | 28 | 29 | 29 | 120 | 652 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 5 | 9 | 11 | 19 | 23 | 32 | 27 | 28 | 28 | 120 | 652 |
| Total Assets | 0 | 5 | 9 | 11 | 20 | 23 | 36 | 28 | 29 | 29 | 120 | 652 |
Cash Flow
₹ Cr| Particulars | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 0 | −2 | 0 | 0 | −7 | 0 | −3 | −7 | 3 | 0 | −16 | −323 |
| Investing | 0 | 0 | 0 | 0 | 0 | 0 | −3 | 3 | 0 | 0 | 0 | 0 |
| Financing | 0 | 2 | 1 | 0 | 7 | 1 | 7 | 3 | −3 | 0 | 28 | 358 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −1 | 0 | 0 | 12 | 35 |
| Free Cash Flow | 0 | −2 | 0 | 0 | −7 | 0 | −4 | −7 | 3 | 0 | −16 | −323 |
| CFO/EBITDA | — | −857 | −39 | 40 | −431 | 4 | −227 | 91 | −59 | 28 | 3,560 | −3,220 |
Ratios
| Particulars | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | — | 125 | 87 | 56 | 111 | 78 | 112 | 95 | 261 | 217 | 1,225 | 108 |
| Inventory Days | — | 71 | 78 | 108 | 91 | 86 | 97 | 122 | 179 | 392 | 1,439 | 1 |
| Days Payable | — | 113 | 107 | 83 | 77 | 54 | 83 | 10 | 18 | — | 7 | 85 |
| Cash Conversion Cycle | — | 82 | 58 | 82 | 125 | 111 | 126 | 207 | 422 | — | 2,657 | 24 |
| Working Capital Days | — | 81 | 24 | 34 | 64 | 57 | 79 | 143 | 279 | 472 | 5,034 | 160 |
| ROCE % | 0% | 22% | 21% | 22% | 25% | 24% | 17% | 4% | 12% | 12% | 1% | 4% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Murae Organisor insights
56 extracted metrics across FY14–FY26.
Documents
- 22 May 2025
- 21 Feb 2026
- General announcements 2 Oct 2025
Frequently Asked Questions about Murae Organisor
What does Murae Organisor Ltd do?
Where is Murae Organisor Ltd (MURAE) listed?
Which sector does Murae Organisor Ltd belong to?
What is the Return on Equity (ROE) of Murae Organisor Ltd?
Company Information
Incorporated in 2012, Murae Organisor Ltd is in the business of pharma commodities trading
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/542724.md for Murae Organisor Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.